Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ERM
EquityCompass Risk Manager ETF
$23.09
-0.2%
$23.09
$20.72
$23.15
$16.86M0.834,740 shs600 shs
Forty Seven Inc stock logo
FTSV
Forty Seven
$95.51
$95.51
$5.53
$95.51
$4.60B0.41.61 million shsN/A
Interfor Co. stock logo
IFP
Interfor
C$12.54
-0.8%
C$13.18
C$12.17
C$21.44
C$649.40M2.54201,867 shs176,934 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ERM
EquityCompass Risk Manager ETF
0.00%0.00%0.00%0.00%0.00%
Forty Seven Inc stock logo
FTSV
Forty Seven
0.00%0.00%0.00%0.00%0.00%
Interfor Co. stock logo
IFP
Interfor
0.00%-1.02%-0.86%-15.45%-23.49%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ERM
EquityCompass Risk Manager ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Forty Seven Inc stock logo
FTSV
Forty Seven
N/AN/AN/AN/AN/AN/AN/AN/A
Interfor Co. stock logo
IFP
Interfor
2.1906 of 5 stars
3.20.01.70.02.00.80.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ERM
EquityCompass Risk Manager ETF
2.61
Moderate Buy$23.09N/A
Forty Seven Inc stock logo
FTSV
Forty Seven
0.00
N/AN/AN/A
Interfor Co. stock logo
IFP
Interfor
2.43
HoldC$20.0059.49% Upside

Current Analyst Ratings Breakdown

Latest PGIT, CIP, IFP, ERM, and FTSV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2025
Interfor Co. stock logo
IFP
Interfor
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$22.50 ➝ C$20.00
4/30/2025
Interfor Co. stock logo
IFP
Interfor
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetStrong-Buy ➝ Sector PerformC$26.00 ➝ C$22.00
4/22/2025
Interfor Co. stock logo
IFP
Interfor
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperformC$26.00 ➝ C$21.00
4/22/2025
Interfor Co. stock logo
IFP
Interfor
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutralC$20.00 ➝ C$17.00
4/17/2025
Interfor Co. stock logo
IFP
Interfor
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHoldC$20.00 ➝ C$16.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ERM
EquityCompass Risk Manager ETF
N/AN/AN/AN/AN/AN/A
Forty Seven Inc stock logo
FTSV
Forty Seven
$15.68M293.33N/AN/A$7.52 per share12.70
Interfor Co. stock logo
IFP
Interfor
C$3.08B0.21C$1.47 per share8.52C$29.27 per share0.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ERM
EquityCompass Risk Manager ETF
N/AN/A14.17N/AN/AN/AN/AN/A
Forty Seven Inc stock logo
FTSV
Forty Seven
-$87.62M-$2.34N/AN/AN/AN/A-50.38%-44.35%N/A
Interfor Co. stock logo
IFP
Interfor
-C$426.19M-C$8.18N/AN/A-13.82%-25.85%-4.54%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ERM
EquityCompass Risk Manager ETF
$0.351.52%N/AN/AN/A
Forty Seven Inc stock logo
FTSV
Forty Seven
N/AN/AN/AN/AN/A
Interfor Co. stock logo
IFP
Interfor
N/A12.47%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ERM
EquityCompass Risk Manager ETF
N/AN/AN/A
Forty Seven Inc stock logo
FTSV
Forty Seven
N/A
14.81
14.81
Interfor Co. stock logo
IFP
Interfor
61.24
1.69
1.15

Institutional Ownership

CompanyInstitutional Ownership
ERM
EquityCompass Risk Manager ETF
N/A
Forty Seven Inc stock logo
FTSV
Forty Seven
71.77%
Interfor Co. stock logo
IFP
Interfor
52.81%

Insider Ownership

CompanyInsider Ownership
ERM
EquityCompass Risk Manager ETF
N/A
Forty Seven Inc stock logo
FTSV
Forty Seven
37.40%
Interfor Co. stock logo
IFP
Interfor
0.94%
CompanyEmployeesShares OutstandingFree FloatOptionable
ERM
EquityCompass Risk Manager ETF
N/A730,000N/ANot Optionable
Forty Seven Inc stock logo
FTSV
Forty Seven
5748.16 millionN/ANot Optionable
Interfor Co. stock logo
IFP
Interfor
5,39051.79 millionN/ANot Optionable

Recent News About These Companies

Interfor Corporation (IFP.TO) - Yahoo Finance
Interfor Reports Q1’25 Results
TSX:IFP (Interfor Corporation)
(IFP) Stock Trading Blueprint

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

EquityCompass Risk Manager ETF NYSEARCA:ERM

$23.09 -0.04 (-0.17%)
As of 07/14/2023

The EquityCompass Risk Manager ETF (ERM) is an exchange-traded fund that is based on the S&P 500 index. The fund is an actively-managed, long-only fund that provides long-term capital appreciation with capital preservation as a secondary objective. ERM was launched on Apr 10, 2017 and is managed by First Trust.

Forty Seven stock logo

Forty Seven NASDAQ:FTSV

Forty Seven Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody. Forty Seven Inc. has a collaboration agreement with Genentech to include third clinical trial in non-Hodgkin's lymphoma. The company was formerly known as CD47 Sciences, Inc. Forty Seven Inc. was incorporated in 2014 and is headquartered in Menlo Park, California.

Interfor stock logo

Interfor TSE:IFP

C$12.54 -0.10 (-0.79%)
As of 04:00 PM Eastern

Interfor Corporation, together with its subsidiaries, produces and sells wood products in Canada, the United States, Japan, China, Taiwan, and internationally. It offers decking, fascia and board, framing, v-joint paneling, fineline paneling, and siding products, as well as appearance, structural, studs, timbers, and machine stress related products. The company also provides stock for windows and doors; supplies specialty materials; and logs and wood chips. Its products are used for residential, commercial, and industrial applications. The company was formerly known as International Forest Products Limited and changed its name to Interfor Corporation in May 2014. Interfor Corporation was incorporated in 1963 and is headquartered in Burnaby, Canada.